June 21, 2019
A new program led by The University of Kansas Cancer Center seeks to improve community oncology providers’ knowledge of genetic testing in breast cancer care patients, as well as provide tools to allow genetic counseling and testing to be incorporated in their clinical practice. Called “ePOST BC” (Efficacy of Point of Service Testing in Breast Cancer), the program is based on the Project ECHO model, which links specialists at academic institutions with primary care clinicians in local communities.
According to principal investigators Jennifer Klemp, PhD, MPH, and Lauren Nye, MD, conducting germline genetic testing in those with breast cancer can help determine optimal treatment and prevention strategies. “With the availability of next-generation sequencing, we have access to convenient and low-cost genetic testing. The majority of breast cancer patients meeting testing criteria have not been tested, and this burden will continue to grow,” Dr. Klemp said.
Dr. Klemp added that discrepancies in testing often exist in rural and socioeconomically disadvantaged communities, such as those throughout Kansas. Barriers to genetic testing include lack of access to genetic experts, high drop-out rate for those referred to genetic counseling, patient anxiety and low priority views of testing.
“The goal is to achieve a 50% cancer genetic testing rate in eligible patients,” Dr. Nye said. “Through this program we hope to identify the key elements that are sustainable and applicable for widespread adaptation of point-of-service genetic testing.”
The program is funded by The Association of Community Cancer Centers and Pfizer.
The Masonic Cancer Alliance, KU Cancer Center’s outreach network, partners with cancer research, care, and support professionals to advance the quality and accessibility of cancer prevention, detection, treatment and survivorship in the Heartland.